Jefferies Group KROS Holdings History
Number of Shares
633,671.00
Current Holdings Value*
$41.95 Mil
% of Portfolio
0.4%
Total Estimate Gain
$-5.80 Mil
% of Total Estimate Gain
-15.61%
Jefferies Group's Keros Therapeutics Inc Holding Summary
As of 2024-03-31, Leucadia National held 633,671.00 shares of Keros Therapeutics Inc(KROS), totaling $41.95 Mil. This investment constitutes 0.4% of their stock portfolio, and Leucadia National now holds 1.76% of the outstanding Keros Therapeutics Inc(KROS) stock.
The initial trade took place in 2023Q4. And since then Jefferies Group has made 2 purchases of KROS, at an average price of $58.60, for a total of 633,671.00 shares. Based on historical transaction data and KROS's current price of $49.45, Jefferies Group's estimated gain on his KROS holdings is $-5.80 Mil, reflecting a -15.61% gain to date.
Jefferies Group KROS ($49.45) Holding Chart
Jefferies Group KROS ($49.45) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1